Achilles Therapeutics Statistics
Total Valuation
AMS has a market cap or net worth of $16.20 million. The enterprise value is $31.14 million.
Important Dates
The next confirmed earnings date is Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMS has 6.45 million shares outstanding. The number of shares has increased by 1.70% in one year.
| Current Share Class | 6.45M |
| Shares Outstanding | 6.45M |
| Shares Change (YoY) | +1.70% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 29.80% |
| Owned by Institutions (%) | 13.18% |
| Float | 3.35M |
Valuation Ratios
The trailing PE ratio is 12.09.
| PE Ratio | 12.09 |
| Forward PE | n/a |
| PS Ratio | 0.57 |
| Forward PS | 1.10 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.06 |
| EV / EBITDA | 5.04 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 4.00 |
| Debt / FCF | n/a |
| Interest Coverage | -0.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -0.05% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $356,720 |
| Profits Per Employee | -$29,756 |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -564,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.82% in the last 52 weeks. The beta is 0.31, so AMS's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -12.82% |
| 50-Day Moving Average | 2.48 |
| 200-Day Moving Average | 2.84 |
| Relative Strength Index (RSI) | 57.29 |
| Average Volume (20 Days) | 4,148 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AMS had revenue of $29.25 million and -$2.44 million in losses. Loss per share was -$0.37.
| Revenue | 29.25M |
| Gross Profit | 13.22M |
| Operating Income | -40,000 |
| Pretax Income | 860,000 |
| Net Income | -2.44M |
| EBITDA | 6.18M |
| EBIT | -40,000 |
| Loss Per Share | -$0.37 |
Full Income StatementBalance Sheet
The company has $11.24 million in cash and $25.68 million in debt, giving a net cash position of -$14.43 million or -$2.24 per share.
| Cash & Cash Equivalents | 11.24M |
| Total Debt | 25.68M |
| Net Cash | -14.43M |
| Net Cash Per Share | -$2.24 |
| Equity (Book Value) | 29.21M |
| Book Value Per Share | 3.82 |
| Working Capital | n/a |
Full Balance SheetMargins
Gross margin is 45.18%, with operating and profit margins of -0.14% and -8.34%.
| Gross Margin | 45.18% |
| Operating Margin | -0.14% |
| Pretax Margin | -14.55% |
| Profit Margin | -8.34% |
| EBITDA Margin | 21.11% |
| EBIT Margin | -0.14% |
| FCF Margin | n/a |
